For people recovering from substance use, the holidays can disrupt routines and heighten the risk of relapsing. A prevention ...

FILE PHOTO: Bottles of prescription painkillers Oxycodone Hydrochloride, 30mg, sit on a counter at a local pharmacy in Provo, Utah, April 25, 2017. REUTERS/George Frey/File Photo A good night’s sleep ...

John M. Kane, MD: When someone first develops a schizophrenia illness, I think one of our biggest challenges is helping that person to prevent the recurrence of a psychotic episode. Someone who ...

For many patients diagnosed with diffuse large B-cell lymphoma (DLBCL), the first step in treatment is a standard regimen of chemotherapy. This approach cures most patients, but research shows that 1 ...

A large meta-analysis sheds light on the best antipsychotic maintenance strategy to prevent relapse in clinically-stable schizophrenia — with some unexpected results that have potential implications ...

Please provide your email address to receive an email when new articles are posted on . Clozapine and second-generation long-acting formulations of certain antipsychotics decreased risk for ...

Is artificial intelligence the key to preventing relapse of severe mental illness? New AI software developed by researchers at Flinders University shows promise for enabling timely support ahead of ...

LITTLE ROCK, Ark. — Researchers at UAMS have been granted $2.5 million from the National Institute on Drug Abuse to determine if a cell phone application can reduce the relapse rate in people with ...

Medical University of South Carolina scientists report in Neuron that they have uncovered a way to restore an opioid-weakened brain pathway in a preclinical model. With funding from the National ...

The authors reviewed the literature to identify high-quality studies (observational and controlled) of ANCA-associated vasculitis that included a predetermined target dose of steroids at the end of ...

An insurance company repeatedly denied a Wisconsin woman coverage for a medication her doctor prescribed to treat her ...

A 2015 study comparing schizophrenia patients who received oral or injectable antipsychotic medications found no difference in relapse rates between the groups. Now, a follow-up study published August ...